• UroGen Pharma (URGN) Is Up 5.8% After FDA Clears IND For UGN-501 Phase 1 Trial simplywall.st Fri, 10 Jul 2026 10:04:09 GMT
• Form 144 UroGen Pharma Ltd. For: 9 July By Investing.com Investing.com UK Thu, 09 Jul 2026 21:23:04 GMT
• Affiliate files Form 144: UroGen (NASDAQ: URGN) sells two 10,000-share blocks Stock Titan Thu, 09 Jul 2026 20:20:06 GMT
• H.C. Wainwright reiterates UroGen Pharma stock rating on FDA clearance By Investing.com Investing.com Nigeria Thu, 09 Jul 2026 11:46:08 GMT
• Urogen Pharma (NASDAQ:URGN) Nears 52-Week High on Minervini Trend Template and High Growth Momentum Screen ChartMill Thu, 09 Jul 2026 11:20:37 GMT
• Is UroGen Pharma (URGN) Undervalued Following FDA Clearance For UGN 501? simplywall.st Thu, 09 Jul 2026 08:46:35 GMT
• Bladder Cancer Oncolytic Virus UGN-501 Cleared by FDA for Phase 1 Trials This Fall Tech Times Wed, 08 Jul 2026 19:44:12 GMT
• UroGen Pharma (URGN) Receives FDA Clearance for IND of UGN-501 GuruFocus Wed, 08 Jul 2026 14:24:44 GMT
• UroGen receives FDA clearance for bladder cancer trial Investing.com Wed, 08 Jul 2026 12:34:54 GMT
• UroGen Announces FDA Clearance of the IND for UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive ... Yahoo Finance Wed, 08 Jul 2026 12:00:00 GMT
• UroGen wins FDA clearance to test bladder cancer virus in Phase 1 Stock Titan Wed, 08 Jul 2026 12:00:00 GMT
• Urogen Pharma (URGN) is a Great Momentum Stock: Should You Buy? Yahoo Finance Tue, 07 Jul 2026 16:00:05 GMT
• UroGen Pharma Ltd focuses on bladder cancer therapies as investors watch long-term prospects AD HOC NEWS Tue, 07 Jul 2026 15:10:03 GMT
• UroGen Pharma (URGN) Stock Looks Overvalued As 257% Returns Raise The Bar simplywall.st Thu, 02 Jul 2026 01:01:19 GMT
• is urogen pharma a stock to sell after its chief medical officer let go of 10,000 shares? Yahoo Finance Wed, 01 Jul 2026 03:58:00 GMT
• urogen pharma (urgn) surges 4.24% as shares approach key resistance level - low vol factor dars.gov.et Tue, 30 Jun 2026 18:32:25 GMT
• Is UroGen Pharma a Stock to Sell After Its Chief Medical Officer Let Go of 10,000 Shares? The Motley Fool Tue, 30 Jun 2026 07:00:00 GMT
• Urogen Pharma stock hits 52-week high at 36.12 USD By Investing.com Investing.com Nigeria Mon, 29 Jun 2026 19:23:10 GMT
• price to book forward of urogen pharma ltd. – nasdaq:urgn TradingView Mon, 29 Jun 2026 17:26:20 GMT
• (urgn) as a liquidity pulse for institutional tactics Stock Traders Daily Mon, 29 Jun 2026 12:36:02 GMT
• Price to earnings forward of UroGen Pharma Ltd. – SWB:UR8 TradingView Sun, 28 Jun 2026 00:40:24 GMT
• price to book forward of urogen pharma ltd. – boats:urgn TradingView Sat, 27 Jun 2026 22:55:44 GMT
• enterprise value to revenue forward of urogen pharma ltd. – swb:ur8 TradingView Sat, 27 Jun 2026 21:24:58 GMT
• enterprise value to ebit forward of urogen pharma ltd. – nasdaq:urgn TradingView Sat, 27 Jun 2026 18:57:08 GMT
• enterprise value to ebitda forward of urogen pharma ltd. – nasdaq:urgn TradingView Sat, 27 Jun 2026 18:22:05 GMT
• URGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc The National Law Review Sat, 27 Jun 2026 14:24:38 GMT
• UroGen Pharma Ltd. (URGN) Investigation: Bronstein, Gewirtz & Gro The National Law Review Sat, 27 Jun 2026 14:21:58 GMT
• URGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno The National Law Review Sat, 27 Jun 2026 13:59:37 GMT
• UroGen Pharma (URGN) director awarded 8,000 RSUs and 10,000 options Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• UroGen Pharma (URGN) director receives 20,000 stock options at $34.99 strike Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• UroGen Pharma (URGN) director receives new RSUs and stock option grant Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• UroGen Pharma (URGN) awards director RSUs and stock options Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• Director at UroGen Pharma (NASDAQ: URGN) granted RSUs and stock options Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• Urogen pharma CMO Mark Schoenberg sells $350,100 in shares Investing.com Wed, 24 Jun 2026 07:00:00 GMT
• UroGen Pharma (URGN) CMO sells 10,000 shares in planned open-market trade Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• Form 4 Urogen Pharma Ltd For: 24 June By Investing.com Investing.com India Wed, 24 Jun 2026 07:00:00 GMT
• form 144 urogen pharma ltd. for: 22 june by investing.com Investing.com Australia Tue, 23 Jun 2026 22:18:34 GMT
• urogen shareholders approve director insurance amendment and 2017 plan increase TradingView Tue, 23 Jun 2026 20:23:01 GMT
• UroGen Pharma (NASDAQ: URGN) OKs new articles and equity plan share increase Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• non-muscle invasive bladder cancer market dynamics to shift during the forecast period (2026-2036) as novel targeted and gene ther... Yahoo Finance Tue, 23 Jun 2026 07:00:00 GMT
• urogen pharma (urgn) director receives new rsus and stock option grant Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• Form 144 UroGen Pharma Ltd. For: 22 June By Investing.com Investing.com Nigeria Mon, 22 Jun 2026 20:10:34 GMT
• urogen pharma (urgn) form 144: director sale of 10,000 shares for $300k Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• urogen pharma stock - saturday overview of strategy and pipeline Ad-hoc-news.de Sat, 20 Jun 2026 19:35:14 GMT
• is urogen pharma a stock to sell after its chief medical officer unloaded 5,222 shares? AOL.com Fri, 19 Jun 2026 01:28:19 GMT
• urogen pharma stock hits 52-week high at 32.5 usd by investing.com Investing.com Nigeria Thu, 18 Jun 2026 10:35:06 GMT
• urogen pharma ltd (urgn) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 01:18:25 GMT
• urogen pharma ltd (urgn) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 00:57:41 GMT
• urogen pharma ltd (urgn) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 14:59:51 GMT
• Why UroGen Pharma (URGN) Is Up 17.2% After Teva Patent Settlement And Zusduri Sales Surge simplywall.st Wed, 17 Jun 2026 07:00:00 GMT
• td cowen maintains urogen pharma ltd(urgn.us) with buy rating, maintains target price $35 Moomoo Tue, 16 Jun 2026 07:00:00 GMT
• urogen pharma ltd (urgn) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• urogen pharma announces inducement grants under nasdaq listing rule 5635(c)(4) 富途牛牛 Mon, 15 Jun 2026 20:25:32 GMT
• Is UroGen Pharma a Stock to Sell After Its Chief Medical Officer Unloaded 5,222 Shares? The Motley Fool Sun, 14 Jun 2026 07:00:00 GMT
• what's driving investor interest in urogen pharma (urgn) ahead of goldman sachs Kavout | AI Wed, 10 Jun 2026 07:00:00 GMT
• transcript : urogen pharma ltd. presents at goldman sachs 47th annual global healthcare conference 2026, jun-10-2026 08 marketscreener.com Wed, 10 Jun 2026 07:00:00 GMT
• urogen pharma ltd stock (il0011408896): focus on urology pipeline after recent clinical updates AD HOC NEWS Tue, 09 Jun 2026 19:03:42 GMT
• UroGen Pharma CMO Mark Schoenberg sells $142,560 in shares Investing.com Tue, 09 Jun 2026 07:00:00 GMT
• UroGen Pharma (URGN) CMO nets shares as RSUs vest and 5,222 sold for tax Stock Titan Tue, 09 Jun 2026 07:00:00 GMT
• Mark Schoeberg sells 10,000 shares of UroGen (URGN) reported in Form 144 Stock Titan Tue, 09 Jun 2026 07:00:00 GMT
• insider sale: chief medical officer of $urgn sells 5,222 shares Quiver Quantitative Tue, 09 Jun 2026 07:00:00 GMT
• how resolving jelmyto patent litigation and setting 2030 generic entry at urogen pharma (urgn) has changed its investment story Sahm Tue, 09 Jun 2026 07:00:00 GMT
• urogen pharma announces inducement grants under nasdaq listing rule 5635(4) marketscreener.com Mon, 08 Jun 2026 09:10:18 GMT
• Will UroGen’s Jelmyto Generic Deal with Teva Redefine UroGen Pharma's (URGN) Narrative? Yahoo Finance Mon, 08 Jun 2026 07:00:00 GMT
• urogen pharma ltd (nasdaq:urgn) flawlessly passes minervini trend template with accelerating growth ChartMill Mon, 08 Jun 2026 07:00:00 GMT
• urogen pharma cmo mark schoenberg sells $142,560 in shares by investing.com Investing.com Nigeria Mon, 08 Jun 2026 07:00:00 GMT
• (urgn) movement as an input in quant signal sets Stock Traders Daily Sun, 07 Jun 2026 09:54:02 GMT
• Assessing UroGen Pharma (URGN) Valuation After Jelmyto Patent Settlement With Teva simplywall.st Sun, 07 Jun 2026 07:00:00 GMT
• 21 new urogen staff get stock units to back cancer drugs Stock Titan Fri, 05 Jun 2026 12:00:00 GMT
• UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Fri, 05 Jun 2026 07:00:00 GMT
• urogen pharma ltd stock (il0011408896): nasdaq inducement grants and valuation metrics in focus AD HOC NEWS Fri, 05 Jun 2026 07:00:00 GMT
• urgn stock price, quote & chart | urogen pharma ltd (nasdaq:urgn) ChartMill Fri, 05 Jun 2026 07:00:00 GMT
• UroGen Pharma, Teva End Patent Dispute Over Urinary Cancer Drug Bloomberg Law News Thu, 04 Jun 2026 07:00:00 GMT
• urgn reiterated by hc wainwright & co. -- price target maintained at $45 GuruFocus Wed, 03 Jun 2026 17:02:23 GMT
• UroGen Pharma stock reaffirmed at Buy by H.C. Wainwright on Teva settlement Investing.com Wed, 03 Jun 2026 07:00:00 GMT
• urogen pharma (urgn) settles patent dispute with teva pharmaceuticals (teva) GuruFocus Tue, 02 Jun 2026 18:14:07 GMT
• UroGen Announces Agreement Resolving Patent Litigation GlobeNewswire Tue, 02 Jun 2026 07:00:00 GMT
• Oppenheimer reiterates Outperform on UroGen Pharma stock after Teva settlement Investing.com Tue, 02 Jun 2026 07:00:00 GMT
• UroGen reaches agreement with Teva resolving patent litigation over Jelmyto Drug Store News Tue, 02 Jun 2026 07:00:00 GMT
• [8-k] urogen pharma ltd. reports material event | urgn 8-k filing Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• teva gets sept. 15, 2030 license for generic jelmyto drug Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• urogen settles with teva over jelmyto patent row (urgn:nasdaq) Seeking Alpha Tue, 02 Jun 2026 07:00:00 GMT
• urogen pharma to present at the goldman sachs 47th annual global healthcare conference The Manila Times Tue, 02 Jun 2026 07:00:00 GMT
• urgn stock price, quote & chart | urogen pharma ltd (nasdaq:urgn) ChartMill Tue, 02 Jun 2026 07:00:00 GMT
• What's Driving Investor Interest in UroGen Pharma (URGN) Ahead of Goldman Sachs Kavout | AI Tue, 02 Jun 2026 00:02:24 GMT
• what's driving investor interest in urogen pharma (urgn) ahead of goldman sachs Kavout Mon, 01 Jun 2026 22:02:24 GMT
• Hear UroGen’s Goldman Sachs healthcare chat online with 90-day replay Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• urogen pharma to present at the goldman sachs 47th annual global healthcare conference Yahoo Finance Mon, 01 Jun 2026 07:00:00 GMT
• urogen pharma ltd stock (il0011408896): recent gains put valuation in focus AD HOC NEWS Fri, 29 May 2026 17:46:57 GMT
• what to know about this fund's $6.6 million urogen sale after a 600% stock surge AOL.com Fri, 29 May 2026 13:35:26 GMT
• urgn stock price, quote & chart | urogen pharma ltd (nasdaq:urgn) ChartMill Fri, 29 May 2026 07:00:00 GMT
• what to know about this fund's $6.6 million urogen sale after a 600% stock surge AOL.com Wed, 27 May 2026 14:11:02 GMT
• UroGen Pharma (URGN) director converts 2,000 RSUs into ordinary shares, holds 6,000 Stock Titan Wed, 27 May 2026 07:00:00 GMT
• urgn: zusduri adoption accelerates with robust q1 growth and pipeline advances set for 2024-2027 TradingView Tue, 26 May 2026 15:49:39 GMT
• h.c. wainwright maintains urogen pharma ltd(urgn.us) with buy rating, maintains target price $45 富途牛牛 Tue, 26 May 2026 07:00:00 GMT
• urogen pharma (urgn) just flashed golden cross signal: do you buy? MSN Mon, 25 May 2026 11:43:48 GMT
• how ugn-103’s phase 3 data and nda timeline could reshape urogen pharma (urgn) investors’ outlook simplywall.st Sun, 24 May 2026 14:25:10 GMT
• what to know about this fund's $6.6 million urogen sale after a 600% stock surge AOL.com Sun, 24 May 2026 07:13:14 GMT
• What to Know About This Fund's $6.6 Million UroGen Sale After a 600% Stock Surge The Motley Fool Sat, 23 May 2026 07:00:00 GMT
• urogen pharma (urgn) just flashed golden cross signal: do you buy? MSN Sat, 23 May 2026 02:08:11 GMT
• tyra creates awareness day to shine light on a rare cancer Fierce Pharma Fri, 22 May 2026 08:21:46 GMT
• Tyra creates awareness day with patient advocates to shine light on a rare cancer Fierce Pharma Fri, 22 May 2026 07:00:00 GMT
• urgn stock price, quote & chart | urogen pharma ltd (nasdaq:urgn) ChartMill Fri, 22 May 2026 07:00:00 GMT
• How UGN-103’s Strong Phase 3 UTOPIA Data Could Shape UroGen Pharma (URGN) Investors Yahoo Finance Thu, 21 May 2026 07:00:00 GMT
• urgn stock price, quote & chart | urogen pharma ltd (nasdaq:urgn) ChartMill Thu, 21 May 2026 07:00:00 GMT
• wall street analysts are bullish on top healthcare picks The Globe and Mail Wed, 20 May 2026 12:40:00 GMT
• oppenheimer maintains urogen pharma ltd(urgn.us) with buy rating, maintains target price $40 Moomoo Wed, 20 May 2026 07:56:54 GMT
• oppenheimer reiterates outperform on urogen pharma stock by investing.com Investing.com Nigeria Wed, 20 May 2026 00:09:57 GMT
• oppenheimer maintains urogen pharma ltd(urgn.us) with buy rating, maintains target price $40 富途牛牛 Tue, 19 May 2026 12:31:00 GMT
• Oppenheimer reiterates Outperform on UroGen Pharma stock Investing.com Tue, 19 May 2026 07:00:00 GMT
• urogen pharma investor event reinforced zusduri commercial thesis, oppenheimer says Moomoo Tue, 19 May 2026 07:00:00 GMT
• urogen pharma ltd. (urgn) faces securities class action amid fda GuruFocus Mon, 18 May 2026 16:00:11 GMT
• urogen pharma (urgn) just flashed golden cross signal: do you buy? MSN Mon, 18 May 2026 14:12:40 GMT
• h.c. wainwright reiterates urogen pharma stock rating on durability data Investing.com India Mon, 18 May 2026 12:05:50 GMT
• urogen pharma: buy rating reiterated as strong zusduri data and ugn-103 pipeline support unchanged $45 price target TipRanks Mon, 18 May 2026 11:19:28 GMT
• urogen pharma price target maintained with a $45.00/share by hc wainwright & co. Moomoo Mon, 18 May 2026 10:39:00 GMT
• how strong ugn-103 phase 3 durability data at urogen pharma (urgn) has changed its investment story Sahm Mon, 18 May 2026 07:47:56 GMT
UroGen Pharma Ltd(NASDAQ:URGN) 
UroGen Pharma Ltd., a biopharmaceutical company, engages in the development and commercialization novel solutions for specialty cancers and urologic diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmy...
Website: http://www.urogen.com
Founded: 2004
Full Time Employees: 187
Sector: Healthcare
Industry: Biotechnology